spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  fluorescence in situ hybridization 

 HSMN NewsFeed - 24 Feb 2017
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno(TM) System and Accelerate PhenoTest(TM) BC Kit
Diagnostics FDA
 HSMN NewsFeed - 31 Aug 2016
XALKORI(R) (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Nov 2014
AdvanDx Receives FDA 510(k) Clearance for mecA XpressFISH(TM)
Diagnostics FDA
 HSMN NewsFeed - 13 Mar 2014
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
Diagnostics
 HSMN NewsFeed - 10 Mar 2014
CombiMatrix Hires R. Weslie Tyson, M.D., as Chief Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 27 Mar 2013
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 24 Oct 2012
Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 26 Jun 2012
Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
Diagnostics Oncology
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 20 Feb 2012
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
Diagnostics Oncology FDA
 HSMN NewsFeed - 26 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Diagnostics Personalized Medicine Oncology FDA
 HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
Diagnostics Personalized Medicine FDA
 HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jul 2009
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 5 May 2009
AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R)
Diagnostics FDA
 HSMN NewsFeed - 6 Jan 2009
New Milestones for Ikonisys’ oncoFISH(R) cervical Test
Diagnostics Oncology
 HSMN NewsFeed - 7 Mar 2008
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2007
AdvanDx and bioMerieux Partner to Provide Rapid Results for Bloodstream Infections
Diagnostics
 HSMN NewsFeed - 3 May 2007
Enzo Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott
Diagnostics Licensing
 HSMN NewsFeed - 25 Jan 2007
FDA Clears BioView Duet(TM) System for Automated FISH Scanning of Breast Cancer Tissue Specimens
Diagnostics Oncology FDA
 HSMN NewsFeed - 24 Jan 2007
Ikonisys Receives FDA Clearance for Automated Bladder Cancer Test
Devices Diagnostics Oncology FDA
 HSMN NewsFeed - 4 Dec 2006
Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia
Diagnostics Oncology
 HSMN NewsFeed - 28 Sep 2006
Ikonisys Receives FDA Clearance for Prenatal Testing Application
Diagnostics FDA
 HSMN NewsFeed - 20 Jul 2006
New Study in Journal of Urology Shows UroVysion(TM) DNA Test Superior to Standard Cytology in Diagnosing Bladder Cancer in At-Risk Patients
Diagnostics Urology Oncology
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
fluorescence in situ hybridization
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.